Investor Relations

Press Release

March 29, 2021

Amphastar Pharmaceuticals Receives FDA Approval for Dextrose Injection

More
March 15, 2021

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2020

More
March 8, 2021

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 15th, 2021

More
February 26, 2021

Amphastar Pharmaceuticals to Present at the Raymond James 2021 Institutional Healthcare Conference

More
December 29, 2020

Amphastar Announces Approval for Glucagon for Injection Kit, 1mg

More
November 6, 2020

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2020

More
October 29, 2020

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2020

More
October 6, 2020

Amphastar Pharmaceuticals Receives FDA Approval for Atropine Sulfate Injection

More
September 3, 2020

Amphastar Pharmaceuticals to Present at the Wells Fargo 2020 Virtual Healthcare Conference

More
August 6, 2020

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2020

More